CN101102772A - 一种含有石杉碱甲、乙复合成分的蛇足石杉组合物及其制备方法 - Google Patents

一种含有石杉碱甲、乙复合成分的蛇足石杉组合物及其制备方法 Download PDF

Info

Publication number
CN101102772A
CN101102772A CNA2005800470129A CN200580047012A CN101102772A CN 101102772 A CN101102772 A CN 101102772A CN A2005800470129 A CNA2005800470129 A CN A2005800470129A CN 200580047012 A CN200580047012 A CN 200580047012A CN 101102772 A CN101102772 A CN 101102772A
Authority
CN
China
Prior art keywords
huperzine
composition
huperzia serrata
extract
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2005800470129A
Other languages
English (en)
Other versions
CN100566714C (zh
Inventor
谢德隆
谢家骏
王军
黄新生
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Tianci Life Science Development Co ltd
Original Assignee
Xie Jiajun
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xie Jiajun filed Critical Xie Jiajun
Publication of CN101102772A publication Critical patent/CN101102772A/zh
Application granted granted Critical
Publication of CN100566714C publication Critical patent/CN100566714C/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

本发明涉及天然药物技术领域，具体涉及蛇足石杉的生物碱提取物。本发明提供了一种蛇足石杉生物碱组合物及其制备方法。本发明的蛇足石杉组合物包含石杉碱甲和石杉碱乙，其中石杉碱甲和石杉碱乙的总含量以重量％表示为总生物碱的50％-99％，两者的重量比为1∶0.5-5。本发明蛇足石杉生物碱组合物具有良好的治疗效果，且安全性更高。

Description

PCT国内申请，说明书已公开。

Claims (1)

  1. PCT国内申请，权利要求书已公开。
CNB2005800470129A 2004-11-26 2005-11-24 一种含有石杉碱甲、乙复合成分的蛇足石杉组合物及其制备方法 Active CN100566714C (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNB2004100846331A CN100441200C (zh) 2004-11-26 2004-11-26 石杉碱甲、乙复合成分的蛇足石杉提取物及其制备方法
CN200410084633.1 2004-11-26
PCT/CN2005/001992 WO2006056129A1 (fr) 2004-11-26 2005-11-24 Compositions d'alcaloides d'huperzia serrata comportant de l'huperzine a et de l'huperzine b et preparation de ces compositions

Publications (2)

Publication Number Publication Date
CN101102772A true CN101102772A (zh) 2008-01-09
CN100566714C CN100566714C (zh) 2009-12-09

Family

ID=34869239

Family Applications (2)

Application Number Title Priority Date Filing Date
CNB2004100846331A Active CN100441200C (zh) 2004-11-26 2004-11-26 石杉碱甲、乙复合成分的蛇足石杉提取物及其制备方法
CNB2005800470129A Active CN100566714C (zh) 2004-11-26 2005-11-24 一种含有石杉碱甲、乙复合成分的蛇足石杉组合物及其制备方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CNB2004100846331A Active CN100441200C (zh) 2004-11-26 2004-11-26 石杉碱甲、乙复合成分的蛇足石杉提取物及其制备方法

Country Status (3)

Country Link
US (1) US8574633B2 (zh)
CN (2) CN100441200C (zh)
WO (1) WO2006056129A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109613156A (zh) * 2018-09-06 2019-04-12 万邦德制药集团股份有限公司 一种石杉碱甲及石杉碱甲注射液有关物质的检测方法

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8778986B1 (en) * 2007-01-25 2014-07-15 University Of South Florida Treatment of glycogen synthase kinase-based disease
CN101658544B (zh) * 2008-08-30 2012-07-18 浙江万邦药业股份有限公司 千层塔控释片及其制造方法
CN102603730A (zh) * 2011-01-25 2012-07-25 苏州宝泽堂医药科技有限公司 一种从伸筋草中提取石松碱的方法
WO2013142370A1 (en) * 2012-03-19 2013-09-26 Varghese John APP SPECIFIC BACE INHIBITORS (ASBIs) AND USES THEREOF
CN102872016A (zh) * 2012-03-22 2013-01-16 北京阜康仁生物制药科技有限公司 一种药物组合物
CN103667070A (zh) * 2013-08-08 2014-03-26 浙江医药高等专科学校 蛇足石杉植物内生真菌及其在制备石杉碱甲中的应用
CN103462940A (zh) * 2013-09-17 2013-12-25 浙江省医学科学院 一种石杉碱甲微乳型巴布剂
CN103705548B (zh) * 2014-01-10 2015-11-04 吉首大学 一种活体提取蛇足石杉生物总碱的方法
KR101784413B1 (ko) * 2015-04-14 2017-10-12 대구가톨릭대학교산학협력단 석송강 추출물 또는 이로부터 분리된 화합물을 포함하는 알츠하이머병의 예방 또는 치료용 조성물-ⅰ
ES2767086T3 (es) * 2015-06-15 2020-06-16 Neuralia Composición de combinación que comprende huperzina
CN105061310B (zh) * 2015-08-31 2018-01-12 桂林三宝生物科技有限公司 一种从千层塔中提取石杉碱甲的方法
CN108314651A (zh) * 2018-05-14 2018-07-24 上海华堇生物技术有限责任公司 一种石杉碱甲的新制备方法
CN110372592B (zh) * 2019-07-11 2022-06-28 中国科学院昆明植物研究所 14-羟基玉柏石松醇碱及其药物组合物与其制备方法和应用
CN111349046B (zh) * 2020-03-13 2022-03-15 西北大学 一种生物碱、晶体、制备方法及应用
CN112402466B (zh) * 2020-11-30 2022-04-19 湖南华诚生物资源股份有限公司 从千层塔提取物中分离总生物碱的方法
CN112457251B (zh) * 2020-11-30 2022-04-15 湖南华诚生物资源股份有限公司 从千层塔提取物中分离多种高含量生物碱单体的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5177082A (en) * 1985-11-05 1993-01-05 Yu Chao Mei Huperzines and analogs
CN1047732A (zh) 1990-04-28 1990-12-12 黄斌夫 双层三环四带轮窑
CN1037359C (zh) 1993-10-07 1998-02-11 化学工业部化工机械研究院 高温合金炉管的回收再生技术
CN1047732C (zh) * 1995-04-10 1999-12-29 浙江省医学科学院 石杉碱透皮吸收贴片
CN1279065A (zh) * 1999-07-06 2001-01-10 青岛科达生物工程有限公司 一种治疗记忆障碍和老年痴呆的药物组合物
CN1240384C (zh) * 1999-11-04 2006-02-08 美国爱科赛尔制药有限公司 石杉碱经皮给药制剂
CN1101381C (zh) * 2000-01-21 2003-02-12 浙江大学 乙酰胆碱酯酶抑制剂石杉碱甲的提取方法
ITRM20010218A1 (it) * 2001-04-23 2002-10-23 Sigma Tau Healthscience Spa Composizione per la prevenzione o il trattamento dei disturbi dell'apprendimento in bambini affetti da deficit dell'attenzione ed iperattivi
CN1207285C (zh) * 2002-03-28 2005-06-22 河南竹林众生制药股份有限公司 从中草药千层塔中提取石杉碱甲的方法
CN1383824A (zh) * 2002-05-21 2002-12-11 浙江省医学科学院 石杉碱鼻腔给药制剂

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109613156A (zh) * 2018-09-06 2019-04-12 万邦德制药集团股份有限公司 一种石杉碱甲及石杉碱甲注射液有关物质的检测方法

Also Published As

Publication number Publication date
CN1644208A (zh) 2005-07-27
CN100441200C (zh) 2008-12-10
WO2006056129A1 (fr) 2006-06-01
US8574633B2 (en) 2013-11-05
US20070286911A1 (en) 2007-12-13
CN100566714C (zh) 2009-12-09

Similar Documents

Publication Publication Date Title
CN101102772A (zh) 一种含有石杉碱甲、乙复合成分的蛇足石杉组合物及其制备方法
CN100371707C (zh) 测定银杏叶组合物中萜内酯含量的方法
CN102283870B (zh) 一种高纯度银杏叶组合物，含其制剂及其制备方法
CN101554409B (zh) 荜茇生物碱及其制备方法、制剂和用途
WO2009009952A1 (fr) Extrait de rehmannia glutinasa libosch pour réduire la glycémie et la lipidémie, traiter une leucémie, son procédé de préparation et ses utilisations
CN101045072A (zh) 山香圆叶提取物及其医药用途
CN103083557A (zh) 具有降血压和降血脂作用的中药组合物
WO2008145064A1 (fr) Procédé d'obtention d'un extrait contenant du séquoyitol à partir d'une espèce du genre trifolium, de soja et de ginkgo biloba, et utilisation de celui-ci
CN103860638B (zh) 苦豆子黄酮组合物的制备方法及医药新用途
CN104224863B (zh) 金钱草总黄酮在制备治疗高尿酸血症药物中的应用
CN101040937B (zh) 肠炎宁片的检测方法
CN105079085A (zh) 一种镰形棘豆总黄酮的提取工艺
CN105566436B (zh) 一种茶籽黄酮苷元并茶皂苷元锌配合物及其制法和用途
CN102875615B (zh) 大麻药苷a和大麻药总皂苷的提取方法及其应用
CN102827001A (zh) 一种苦丁茶冬青提取物
CN113730463A (zh) 香连丸产物的新用途
CN103446456B (zh) 治疗高血压和高血脂疾病的方法和使用的中药组合物
CN102145043A (zh) 一种治疗心血管疾病的药物组合物及其制剂，以及制剂的制备方法
CN106361811B (zh) 一种通脉药物组合物及其制备方法
CN101721434B (zh) 一种阿里红有效组分及其制备方法和用途
CN100444849C (zh) 刺蒺藜提取物的新用途
CN102631386B (zh) 柴胡解热镇痛制剂及其制备工艺
CN102018741A (zh) 金盏银盘总黄酮提取物、制备工艺及其制剂
CN105362259B (zh) 一种具有降尿酸作用的山核桃叶提取物球松素及其制备方法和用途
CN110898170B (zh) 一种治疗代谢综合征的中药组合物及其制剂

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20100115

Address after: 23-B, 2 building, 398 South Henan Road, Shanghai, China, zip code: 200010

Co-patentee after: Xie Jiajun

Patentee after: Xie De Long

Co-patentee after: Wang Jun

Address before: 23-B, 2 building, 398 South Henan Road, Shanghai, China, zip code: 200010

Co-patentee before: Xie Jiajun

Patentee before: Xie De Long

Co-patentee before: Wang Jun

Co-patentee before: Huang Xinsheng

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20160617

Address after: 201203 Edison road Shanghai, Pudong New Area Zhangjiang hi tech Park No. 274

Patentee after: SHANGHAI TIANCI BIOLOGICAL VALLEY BIOLOGICAL ENGINEERING CO., LTD.

Address before: 23-B, building 2, building 398, South Henan Road, Shanghai, China

Patentee before: Xie Delong

Patentee before: Xie Jiajun

Patentee before: Wang Jun

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20201225

Address after: 201315 Three 1801-5 workstations at 2388 Xiupu Road, Pudong New Area, Shanghai

Patentee after: Shanghai Tianci Life Science Development Co.,Ltd.

Address before: 201203 No. 274 Edison Road, Zhangjiang High-tech Park, Pudong New Area, Shanghai

Patentee before: SHANGHAI TIN TSZ BIO VALLEY BIOLOGICAL ENGINEERING Co.,Ltd.